Letter Sequence Supplement |
---|
EPID:L-2020-LLA-0054, Massachusetts Institute of Technology (Mit), License Amendment Request for Position Title Change in Technical Specifications for Level 1 Staff (Approved, Closed) |
|
MONTHYEARML20078J4852020-03-12012 March 2020 Massachusetts Institute of Technology (Mit), License Amendment Request for Position Title Change in Technical Specifications for Level 1 Staff Project stage: Request ML20090E2272020-04-16016 April 2020 Massachusetts Institute of Technology - Acceptance of the Application for a License Amendment Level 1 Position Title Change Project stage: Acceptance Review ML20192A0762020-06-30030 June 2020 Mit - Supplemental Information for License Amendment Request for Position Title Change in Technical Specifications for Level 1 Staff Project stage: Supplement ML20161A3342020-07-24024 July 2020 Massachusetts Institute of Technology - Issuance of Amendment NO.44 to Renewed Facility Operation License No. R-37 to Amend Technical Specifications Related to Level 1 Position Title Change Project stage: Approval 2020-04-16
[Table View] |
|
---|
Category:Letter
MONTHYEARIR 05000020/20242012024-09-12012 September 2024 Massachusetts Institute of Technology - U.S. Nuclear Regulatory Commission Safety Inspection Report No. 05000020/2024201 ML24199A1082024-07-23023 July 2024 Examination Confirmation Letter No. 50-020/OL-24-02, Massachusetts Institute of Technology ML24052A2102024-06-0606 June 2024 Examination Result Letter No. 50-020/OL-24-01, Massachusetts Institute of Technology ML24127A1012024-04-26026 April 2024 Mit - Update of Professor Ian A. Waitz Named as Mit Vice President for Research ML24127A1002024-04-24024 April 2024 Mit - Proposal for Conversion to Low Enriched Uranium (Leu), Mit Research Reactor ML24094A0482024-03-29029 March 2024 Mit Nuclear Reactor Lab., Annual Report for 2023, Per Technical Specification 7.7.1 ML24081A1642024-03-11011 March 2024 Massachusetts Institute of Technology, NF-0343 & NW-0681 - Submittal of Rescinding Notice of Cancellation ML24022A0972024-01-22022 January 2024 Massachusetts Institute of Technology– Change of Facility Backup Project Manager ML23354A1442024-01-0505 January 2024 Examination Confirmation Letter No. 50-020/OL-24-01, Massachusetts Institute of Technology IR 05000020/20232032023-11-21021 November 2023 Massachusetts Institute of Technology - U.S. Nuclear Regulatory Commission Routine Inspection Report No. 05000020/2023203 ML23242A3382023-11-0606 November 2023 Examination Report Letter No. 50-020/OL-23-01, Massachusetts Institute of Technology ML23242A3392023-11-0606 November 2023 Examination Result Letter No. 50-020/OL-23-01, Massachusetts Institute of Technology IR 05000020/20232012023-10-12012 October 2023 Massachusetts Institute of Technology - U.S. Nuclear Regulatory Commission Routine Inspection Report No. 05000020/2023201 IR 05000020/20232022023-09-27027 September 2023 Massachusetts Institute of Technology - U.S. Nuclear Regulatory Commission Security Inspection Report No. 05000020/2023202 ML23194A0412023-07-11011 July 2023 Mit Research Reactor - Duties of Reactor Superintendent ML23103A2632023-05-10010 May 2023 Examination Confirmation Letter No. 50-020/OL-23-01 Massachusetts Institute of Technology ML23094A1102023-03-30030 March 2023 Massachusetts Institute of Technology (Mit), Submittal of Annual Report for 2022, Technical Specification 7.7.1 ML23072A0242023-03-0707 March 2023 Mit, Nuclear Reactor Lab., Proposal for Conversion to Low Enriched Uranium (Leu), Mit Research Reactor IR 05000020/20222012023-02-0707 February 2023 Massachusetts Institute of Technology - U.S. Nuclear Regulatory Commission Routine Inspection Report No. 05000020/2022201 ML22189A0492022-07-25025 July 2022 Examination Confirmation Letter No.50-020/OL-22-02, Massachusetts Institute of Technology ML22095A2412022-03-31031 March 2022 Annual Report for the Mit Research Reactor for the Period from January 1, 2021, to December 31, 2021 ML22062B0422022-02-10010 February 2022 Proposal for Conversion to Low Enriched Uranium (Leu), Mit Research Reactor, Docket No. 50-20, 10 CFR 50.64 (c)(2)(ii) of That Paragraph ML21328A2342021-11-29029 November 2021 Examination Confirmation Letter No. 50-020/OL-22-01, Massachusetts Institute of Technology IR 05000020/20212032021-11-0909 November 2021 Massachusetts Institutes of Technology - U.S. Nuclear Regulatory Commission Routine Inspection Report No. 05000020/2021203 IR 05000020/20212012021-09-30030 September 2021 Massachusetts Institute of Technology - U.S. Nuclear Regulatory Commission Routine Inspection Report 05000020/2021201 ML21186A0032021-07-16016 July 2021 Examination Confirmation Letter No. 50-020/OL-21-02, Massachusetts Institute of Technology ML21165A1542021-05-28028 May 2021 Mit - Emergency Plan and Procedures, 10 CFR 50.54(q)(5) ML21140A3622021-05-17017 May 2021 Massachusetts Institute of Technology (Mit) - Supplement to Response to the Request for Additional Information for Battery Upgrade License Amendment Request (EPID: L-2021 -NFA-0000) ML21132A2512021-05-0606 May 2021 Massachusetts Institute of Technology, License No. R-37, Docket No. 50-20, Reportable Occurrence 50-20/2021-: Operation with Less than the Required Staffing on Site; NRC OPS Center Log EN 55212 ML21112A1672021-04-12012 April 2021 Massachusetts Institute of Technology - Physical Security Plan Revision Regarding Biometric Readers ML21105A3602021-04-0707 April 2021 Duties of Reactor Superintendent ML21099A1132021-03-31031 March 2021 Massachusetts Institute of Technology - Annual Report, Docket No. 50-20, License R-37, Technical Specification 7.7.1 ML21091A2082021-03-24024 March 2021 Mit Nuclear Reactor Lab - Response to Request for Additional Information for Battery Upgrade License Amendment Request ML21076A0232021-03-18018 March 2021 Requests for Additional Information - Related to License Amendment Request to Replace Emergency Power System Batteries ML21070A1852021-03-0202 March 2021 Mit Nuclear Reactor Laboratory, License Amendment Request Regarding Emergency Battery Surveillances in Technical Specification 4.6, Docket No. 50-20, License R-37 ML21063A2552021-02-25025 February 2021 Proposal for Conversion to Low Enriched Uranium (Leu), :Mit Research Reactor, Docket No. 50-20, 10 CFR 50.64 (c)(2)(ii) of That Paragraph ML21053A4372021-02-23023 February 2021 Examination Confirmation Letter No. 50-020/OL-21-01, Massachusetts Institute of Technology ML21036A0852021-02-19019 February 2021 Massachusetts Institute of Technology - Acceptance of License Amendment Request to Revise Surveillance Frequency During Extended Reactor Shutdown ML21035A2582021-01-29029 January 2021 Massachusetts Institute of Technology (Mit), Supplement to Technical Specifications Surveillance Frequency Definition Update for Improved Compliance Under 10 CPR 50.36(c)(3) ML20295A4242020-11-16016 November 2020 Notification of Mailing Address Change Regarding Submittal of Fingerprint Cards ML20307A4202020-11-0505 November 2020 Granting of Extension Request to Supplement License Amendment to Revise Surveillance Requirement Frequency ML20304A1172020-10-19019 October 2020 Time Extension Request for LAR on Technical Specifications Surveillance Frequency Update for Improved Compliance Under 10 CFR 50.36(c)(3) for the Mit Research Reactor ML20248H5682020-09-22022 September 2020 Mit Research Reactor Routine Inspection Report with Enforcement Discretion (EA-20-109) - August 2020 ML20161A3342020-07-24024 July 2020 Massachusetts Institute of Technology - Issuance of Amendment NO.44 to Renewed Facility Operation License No. R-37 to Amend Technical Specifications Related to Level 1 Position Title Change ML20182A7092020-07-0909 July 2020 Acceptance Review Amendment Request to Revise Surveillance Frequency - Opportunity to Supplement ML20192A0762020-06-30030 June 2020 Mit - Supplemental Information for License Amendment Request for Position Title Change in Technical Specifications for Level 1 Staff ML20070H2672020-06-0404 June 2020 Examination Report No. 50-020/OL-20-01, Massachusetts Institute of Technology ML20119A8272020-05-29029 May 2020 Massachusetts Institute of Technology - Issuance of Amendment No. 43 Extending Time to Implement License Amendment No. 42 to Facility Operating License No. R-37 ML20149K4142020-05-27027 May 2020 NRC LAR Extension Supplemental Letter 2020-05-27 ML20135H1882020-05-15015 May 2020 Massachusetts Institute of Technology - Exemption from Select Requirements of 10 CFR Part 55, Operators' Licenses 2024-09-12
[Table view] Category:License-Application for Facility Operating License (Amend/Renewal) DKT 50
MONTHYEARML21070A1852021-03-0202 March 2021 Mit Nuclear Reactor Laboratory, License Amendment Request Regarding Emergency Battery Surveillances in Technical Specification 4.6, Docket No. 50-20, License R-37 ML21035A2582021-01-29029 January 2021 Massachusetts Institute of Technology (Mit), Supplement to Technical Specifications Surveillance Frequency Definition Update for Improved Compliance Under 10 CPR 50.36(c)(3) ML20192A0762020-06-30030 June 2020 Mit - Supplemental Information for License Amendment Request for Position Title Change in Technical Specifications for Level 1 Staff ML20078J4852020-03-12012 March 2020 Massachusetts Institute of Technology (Mit), License Amendment Request for Position Title Change in Technical Specifications for Level 1 Staff ML18030A6562018-01-24024 January 2018 Massachusetts Institute of Technology (Mit) - License Amendment Request for Experiment Approval Process Technical Specification ML16139A7862016-05-12012 May 2016 License Amendment Request for Upgrade of the Nuclear Safety System in the Mit Reactor Protection System, Docket No. 50-20, License R-37 ML15159A4032015-05-28028 May 2015 Massachusetts Institute of Technology - License Amendment Request for Dro Qualification Tech Spec ML13262A1292013-09-10010 September 2013 License Amendment Regarding Mit Police Inspection Routine ML0813506112008-05-0707 May 2008 Massachusetts Institute of Technology - Request for License Amendment to Technical Specification No. 5.3, Primary Coolant System. ML0434304662004-12-0101 December 2004 Massachusetts Institute of Technology, Revision to Technical Specification 5.3, Primary Coolant System. 2021-03-02
[Table view] |
Text
MIT NUCLEAR REACTOR LABORATORY AN MIT INTERDEPARTMENTAL CENTER Edward Lau Mail Stop: NW12-122 Phone: 617 253-4211 Assistant Director 138 Albany Street Fax: 617 324-0042 Reactor Operations Cambridge, MA 02139 Email: eslaumit.edu 30 June 2020 U.S. Nuclear Regulatory Commission Washington, D.C. 20555 Attn.: Document Control Desk
Subject:
Supplemental Information for License Amendment Request for Position Title Change in Technical Specifications for Level 1 Staff, Docket No. 50-20, License R-37 The Massachusetts Institute of Technology (MIT) hereby submits supplemental information for its Facility Operating License No. R-37 License Amendment Request {LAR) originally submitted to NRC on 12 March 2020, requesting a position title change in reactor Technical Specifications for Level 1 staff. The proposed title change requires revision to several sections in the Technical Specifications, including page 6-33, which is part of the Quality Management Program for Section 6.5 Generation of Medical Therapy Facility Beams for Human Therapy. Item numberings on page 6-33 were identified as having unintended changes from the original Technical Specifications authority document. The supplemental information consists of the enclosed corrected markup and final versions of page 6-33 of the Technical Specifications.
These supersede the markup and fmal versions of page 6-33 from the 12 March 2020 LAR.
Again, MIT considers the proposed position title change along with the new management structure an improvement to the MIT Nuclear Reactor Laboratory, maintaining the safe and reliable operation of the MIT Reactor, while improving research and utilization.
Sincerely, Edward S. Lau, Assistant Director of Reactor Operations MIT Research Reactor I declare under penalty of perjury that the foregoing is true : d~ =
Executed on 07/01/2020 __c__~c~ ~~q/.~::::;.._____
~~::::::::___ _ __
Date Si ture ELJt
Enclosures:
As stated cc: USNRC - Senior Project Manager Research and Test Reactors Licensing Branch Division of Licensing Projects Office of Nuclear Reactor Regulation USNRC - Senior Reactor Inspector Research and Test Reactors Oversight Branch Division of Licensing Projects Office of Nuclear Reactor Regulation
(i) The review shall be performed by the Director of the MIT Radiation Protection Program or his designate.
(ii) The review shall be performed annually.
(iii) Patient administrations selected for review shall be audited to determine compliance with each of the requirements listed in paragraph (3) above.
(iv) The review shall be written and any items that require further action shall be so designated. Copies of the review shall be provided to the NRL Managing Director for Operations and to the MIT Reactor Safeguards Committee who will evaluate each review and, if required, recommend modifications in this quality management program to meet the requirements of paragraph (3) above. A copy of these reviews will also be provided to each medical use licensee.
c) Records of each review, including the evaluations and findings of the review, shall be retained in an auditable form for three years.
d) The licensee (MIT) shall reevaluate the Quality Management Program's policies and procedures after each annual review to determine whether the program is still effective or to identify actions required to make the program more effective.
- 5. Response to Recordable Event: Within thirty days after the discovery of a recordable event, the event shall be evaluated and a response made that includes:
a) Assembling the relevant facts, including the cause; b) Identifying what, if any, corrective action is required to prevent recurrence; and c) Retaining a record, in an auditable form, for three years, of the relevant facts and what corrective action, if any, was taken.
A copy of any recordable event shall be provided to the affected medical use licensee.
- 6. Records Retention: The following records shall be retained:
a) Each written directive for three years; and b) A record of each administered radiation therapy where a written directive is required in paragraph (3(a)) above, in an auditable form, for three years after the date of administration.
- 7. Program Modification: Modifications may be made to this quality management program to increase the program's efficiency provided that the program's effectiveness is not decreased. All medical use licensees shall be notified of any modifications and provided with a copy of the revised program. The licensee (MIT) shall furnish the modification to the NRC (Region I) within 30 days after the modification has been made.
6-33
(i) The review shall be performed by the Director of the MIT Radiation Protection Program or his designate.
(ii) The review shall be performed annually.
(iii) Patient administrations selected for review shall be audited to determine compliance with each of the requirements listed in paragraph (3) above.
(iv) The review shall be written and any items that require further action shall be so designated. Copies of the review shall be provided to the NRL Managing Director for Operations and to the MIT Reactor Safeguards Committee who will evaluate each review and, if required, recommend modifications in this quality management program to meet the requirements of paragraph (3) above. A copy of these reviews will also be provided to each medical use licensee.
c) Records of each review, including* the evaluations and findings of the review, shall be retained in an auditable form for three years.
d) The licensee (MIT) shall reevaluate the Quality Management Program's policies and procedures after each annual review to determine whether the program is still effective or to identify actions required to make the program more effective.
- 5. Response to Recordable Event: Within thirty days after the discovery of a recordable event, the event shall be evaluated and a response made that includes:
a) Assembling the relevant facts, including the cause; b) Identifying what, if any, corrective action is required to prevent recurrence; and c) Retaining a record, in an auditable form, for three years, of the relevant facts and what corrective action, if any, was taken.
A copy of any recordable event shall be provided to the affected medical use licensee.
- 6. Records Retention: The following records shall be retained:
a) Each written directive for three years; and b) A record of each administered radiation therapy where a written directive is required in paragraph (3(a)) above, in an auditable form, for three years after the date of administration.
- 7. Program Modification: Modifications may be made to this quality management program to increase the program's efficiency provided that the program's effectiveness is not decreased. All medical use licensees shall be notified of any modifications and provided with a copy of the revised program. The licensee (MIT) shall furnish the modification to the NRC (Region I) within 30 days after the modification has been made.
6-33